Articles - Latest

  • An Overview of the Zeta Potential Part 3: Uses and Applications

    Thursday, June 13, 2013
    In Parts 1 and 2 we discussed the concept of the parameter known as the zeta potential and surveyed the techniques available to determine it. In this final Part 3 we will conclude the overview on zeta potential with a glimpse at its practical broad utility and commercial significance through some applications of zeta potential measurement. read more
  • Identification of Legal Highs using Handheld Raman Spectroscopy

    Tuesday, April 30, 2013
    Raman spectroscopy has emerged as a rapid and powerful tool for critical applications in forensic science. The advantage of Raman spectroscopy is that the Raman signal is often selective to pharmacologically active drug substances [1, 2]. On the other hand, pharmacologically inactive substances do not exhibit a Raman signal and their spectra are often masked by fluorescence. This could be advantageous in identifying drug substances, especially new psychoactive substances. read more
  • Implementation of Achiral Supercritical Fluid Chromatography in Drug Development Testing

    Tuesday, April 30, 2013
    In the past decade, packed column supercritical fluid chromatography (SFC) has dominated chiral separation and chiral purification in medicinal chemistry and process chemistry in the pharmaceutical industry. However, SFC is not just limited to chiral separations. It is getting more and more attention in the arena of achiral separation, which has been dominated by reversed-phase liquid chromatography (RPLC). Compared to well-established RPLC, SFC provides higher separation efficiency and faster analyses while offering low operation cost and facile tunable selectivity for method development. read more
  • The Innovator Pipeline: Bioavailability Challenges and Advanced Oral Drug Delivery Opportunities

    Tuesday, April 30, 2013
    Innovation focused on addressing unmet medical need and improving outcomes for patients is one of the central and overarching goals of the life sciences sector, with significant contributions from large biopharmaceutical companies, biotech and specialty pharma companies, drug delivery companies, and academia. For decades the creation of new medicines has increased quality and quantity of life for patients around the globe. Just looking at the past decade reveals great progress on various fronts, including a 40% reduction of cardiovascular deaths in the US, a significant increase of life expectancy of HIV patients, and the advent of cancer medicine–diagnostic combinations, among others [1]. Scientific breakthroughs leading to novel and valuable medicines are benefiting both patients and their caregivers, and ultimately, society. read more
  • An Interview With... Michael Zemo (Market Manager, METTLER TOLEDO Inc)

    Tuesday, April 30, 2013
    Our guarantee is backed by a commitment to efficient automation and the precision engineering that goes into each and every instrument. METTLER TOLEDO’s high sensitivity sensor technology, full-range microbalances in TGAs, and time-saving, reliable autosampler capabilities are a few examples of qualities that provide a high-level of overall satisfaction to our customers. read more
  • Measuring Potential Leachables in Single-Use Manufacturing Assemblies using Total Organic Carbon (TOC) Analysis

    Tuesday, April 30, 2013
    Regulatory agencies are increasingly requesting a more comprehensive evaluation of the potential contamination of biopharmaceuticals from leachables both from the container closure system used to store the biopharmaceutical and other possible sources such as the manufacturing system. To meet this demand, Total Organic Carbon (TOC) has been investigated as a possible technique that can be used to assess leachables from biopharmaceutical manufacturing equipment and thus provide data to assess the potential risk that biopharmaceutical manufacturing leachables pose to patient safety and product quality. read more
  • GMP and Compounding Pharmacies

    Tuesday, April 30, 2013
    It seems self-evident today, but worth remembering, that the pharmaceutical industry exists on a foundation of trust. Patients or even doctors have no way to actually determine the strength, purity and quality of the medicines prescribed and taken. Everyone trusts that the label is accurate and the medicines are pure. This was not always the case and efforts to safeguard our medicine supply led directly to USP, FDA and the GMPs. read more

All Articles - Most Viewed